Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
- CTC 0141 – ADDENDUM 14; U1111-1263-7887
Commercial Sponsor
University of Sydney, OMICO - Outsmarting Cancer Together
Scientific Title
A Single arm, open label, phase II trial of tumour response to alectinib in patients with advanced tumours harbouring ALK gene alterations detected by comprehensive genomic profiling